Propel Bio Management

Propel Bio Management as of March 31, 2024

Portfolio Holdings for Propel Bio Management

Propel Bio Management holds 28 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Applied Therapeutics Comm (APLT) 24.3 $42M 6.1M 6.80
Plains Gp Holdings Lp-cl Comm (HIGH) 15.9 $27M 1.5M 18.25
Tscan Therapeutics Comm (TCRX) 9.7 $17M 2.1M 7.94
Madrigal Pharmaceuticals Comm (MDGL) 6.7 $12M 43k 267.04
Achieve Life Sciences Comm (ACHV) 6.5 $11M 2.5M 4.54
Phathom Pharmaceuticals Comm (PHAT) 5.4 $9.2M 870k 10.62
Akero Therapeutics Comm (AKRO) 4.8 $8.3M 328k 25.26
Fulcrum Therapeutics Comm (FULC) 4.1 $7.1M 750k 9.44
Avidity Biosciences Comm (RNA) 2.7 $4.6M 179k 25.52
Day One Biopharmaceuticals I Comm (DAWN) 2.6 $4.5M 271k 16.52
Ardelyx Comm (ARDX) 2.5 $4.3M 594k 7.30
Athira Pharma Comm (ATHA) 2.4 $4.1M 1.5M 2.74
Kura Oncology Comm (KURA) 1.6 $2.8M 130k 21.33
Telesat Corp Comm (TSAT) 1.5 $2.5M 291k 8.60
Kymera Therapeutics Comm (KYMR) 1.3 $2.3M 56k 40.20
Ishares Mbs Etf Comm (MBB) 1.2 $2.1M 22k 92.42
Syndax Pharmaceuticals Comm (SNDX) 1.2 $2.0M 83k 23.80
Mirum Pharmaceuticals Comm (MIRM) 1.0 $1.8M 70k 25.12
Marinus Pharmaceuticals Comm (MRNS) 1.0 $1.6M 180k 9.04
Kayne Anderson Energy Inf Comm (KYN) 0.9 $1.5M 147k 10.01
Sutro Biopharma Comm (STRO) 0.6 $1.1M 195k 5.65
Trevi Therapeutics Comm (TRVI) 0.5 $897k 260k 3.45
X4 Pharmaceuticals Comm (XFOR) 0.4 $744k 535k 1.39
Eiger Biopharmaceuticals Comm 0.4 $732k 146k 5.00
Ishares Iboxx Investment Comm (LQD) 0.3 $485k 4.5k 108.92
Cybin Comm (CYBN) 0.2 $352k 850k 0.41
Fidelity Inv Mmtrsy 1 680 Comm 0.1 $212k 212k 1.00
Chinook Therapeutics Inc Cvr Comm 0.0 $31k 79k 0.39